本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

LifeStance Health Group, Inc.

6.37
-0.0350-0.55%
成交量:5.82万
成交额:36.96万
市值:24.76亿
市盈率:-202.75
高:6.38
开:6.36
低:6.30
收:6.40
52周最高:8.30
52周最低:3.74
股本:3.89亿
流通股本:1.40亿
量比:0.51
换手率:0.04%
股息:- -
股息率:- -
每股收益(TTM):-0.0314
每股收益(LYR):-0.1515
净资产收益率:-0.62%
总资产收益率:0.26%
市净率:1.66
市盈率(LYR):-42.01

数据加载中...

2025/04/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/27

重要事件披露

Form 8-K - Current report
2024/12/19

重要事件披露

Form 8-K - Current report
2024/11/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/08

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities